IgA Nephropathy trials recruiting in Texas

Fewer than 3 recruiting trials found.

All IgA Nephropathy trials nationally

Cities in Texas

Recruiting trials in Texas

• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
  NCT06712407 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, El Paso, Galveston, Houston
• Study of BHV-1400 in IgA Nephropathy
  NCT07054684 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Houston